To define the clinical relevance of our finding that Fyn phosphorylates 6PGD Y481 upon EGFR activation, we performed immunohistochemistry (IHC) analyses in 117 glioma specimens using anti-6PGD pY481 and anti-Fyn antibodies. Here, EGFR is linked to glioma.